Publication | Open Access

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

Rheumatoid DisorderRheumatologyEpidemiologyAutoimmune DiseaseMedicineRheumatic DiseasesAutoimmunityInflammatory Rheumatic DiseaseInfliximab Anti-drug AntibodiesImmunotherapyPsoriatic ArthritisRisk FactorsRheumatoid Arthritis